| Year |
Citation |
Score |
| 2016 |
de Leeuw AS, van Megen HJ, Kahn RS, Westenberg HG. d-cycloserine addition to exposure sessions in the treatment of patients with obsessive-compulsive disorder. European Psychiatry : the Journal of the Association of European Psychiatrists. 40: 38-44. PMID 27837671 DOI: 10.1016/J.Eurpsy.2016.06.011 |
0.457 |
|
| 2015 |
Feenstra MG, Klompmakers A, Figee M, Fluitman S, Vulink N, Westenberg HG, Denys D. Prazosin addition to fluvoxamine: A preclinical study and open clinical trial in OCD. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26712326 DOI: 10.1016/J.Euroneuro.2015.12.008 |
0.393 |
|
| 2015 |
Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, ... ... Westenberg HG, et al. Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD. The American Journal of Psychiatry. 172: 82-93. PMID 25158072 DOI: 10.1176/Appi.Ajp.2014.13101306 |
0.311 |
|
| 2013 |
Denys D, de Vries F, Cath D, Figee M, Vulink N, Veltman DJ, van der Doef TF, Boellaard R, Westenberg H, van Balkom A, Lammertsma AA, van Berckel BN. Dopaminergic activity in Tourette syndrome and obsessive-compulsive disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 23: 1423-31. PMID 23876376 DOI: 10.1016/J.Euroneuro.2013.05.012 |
0.369 |
|
| 2013 |
van Liempt S, Arends J, Cluitmans PJ, Westenberg HG, Kahn RS, Vermetten E. Sympathetic activity and hypothalamo-pituitary-adrenal axis activity during sleep in post-traumatic stress disorder: a study assessing polysomnography with simultaneous blood sampling. Psychoneuroendocrinology. 38: 155-65. PMID 22776420 DOI: 10.1016/J.Psyneuen.2012.05.015 |
0.409 |
|
| 2012 |
de Kloet CS, Vermetten E, Rademaker AR, Geuze E, Westenberg HG. Neuroendocrine and immune responses to a cognitive stress challenge in veterans with and without PTSD. European Journal of Psychotraumatology. 3. PMID 22893842 DOI: 10.3402/Ejpt.V3I0.16206 |
0.315 |
|
| 2012 |
van der Plasse G, Schrama R, van Seters SP, Vanderschuren LJ, Westenberg HG. Deep brain stimulation reveals a dissociation of consummatory and motivated behaviour in the medial and lateral nucleus accumbens shell of the rat. Plos One. 7: e33455. PMID 22428054 DOI: 10.1371/Journal.Pone.0033455 |
0.328 |
|
| 2012 |
Vulink NC, Westenberg HG, van Nieuwerburgh F, Deforce D, Fluitman SB, Meinardi JS, Denys D. Catechol-O-methyltranferase gene expression is associated with response to citalopram in obsessive-compulsive disorder. International Journal of Psychiatry in Clinical Practice. 16: 277-83. PMID 22414277 DOI: 10.3109/13651501.2011.653375 |
0.354 |
|
| 2012 |
Luykx JJ, Bakker SC, Lentjes E, Boks MP, van Geloven N, Eijkemans MJ, Janson E, Strengman E, de Lepper AM, Westenberg H, Klopper KE, Hoorn HJ, Gelissen HP, Jordan J, Tolenaar NM, et al. Season of sampling and season of birth influence serotonin metabolite levels in human cerebrospinal fluid. Plos One. 7: e30497. PMID 22312427 DOI: 10.1371/Journal.Pone.0030497 |
0.4 |
|
| 2012 |
van Venrooij JA, Fluitman SB, Lijmer JG, Kavelaars A, Heijnen CJ, Westenberg HG, Kahn RS, Gispen-de Wied CC. Impaired neuroendocrine and immune response to acute stress in medication-naive patients with a first episode of psychosis. Schizophrenia Bulletin. 38: 272-9. PMID 20558533 DOI: 10.1093/Schbul/Sbq062 |
0.422 |
|
| 2011 |
Schutters SI, van Megen HJ, Van Veen JF, Schruers KR, Westenberg HG. Paroxetine augmentation in patients with generalised social anxiety disorder, non-responsive to mirtazapine or placebo. Human Psychopharmacology. 26: 72-6. PMID 23055414 DOI: 10.1002/Hup.1165 |
0.365 |
|
| 2011 |
van Liempt S, Westenberg HG, Arends J, Vermetten E. Obstructive sleep apnea in combat-related posttraumatic stress disorder: a controlled polysomnography study. European Journal of Psychotraumatology. 2. PMID 22893807 DOI: 10.3402/Ejpt.V2I0.8451 |
0.315 |
|
| 2011 |
Figee M, Vink M, de Geus F, Vulink N, Veltman DJ, Westenberg H, Denys D. Dysfunctional reward circuitry in obsessive-compulsive disorder. Biological Psychiatry. 69: 867-74. PMID 21272861 DOI: 10.1016/J.Biopsych.2010.12.003 |
0.376 |
|
| 2011 |
Fluitman SB, Heijnen CJ, Denys DA, Nolen WA, Balk FJ, Westenberg HG. Electroconvulsive therapy has acute immunological and neuroendocrine effects in patients with major depressive disorder. Journal of Affective Disorders. 131: 388-92. PMID 21183225 DOI: 10.1016/J.Jad.2010.11.035 |
0.311 |
|
| 2010 |
Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H, Bosch A, Schuurman R. Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Archives of General Psychiatry. 67: 1061-8. PMID 20921122 DOI: 10.1001/Archgenpsychiatry.2010.122 |
0.371 |
|
| 2010 |
Schutters SI, Van Megen HJ, Van Veen JF, Denys DA, Westenberg HG. Mirtazapine in generalized social anxiety disorder: a randomized, double-blind, placebo-controlled study. International Clinical Psychopharmacology. 25: 302-4. PMID 20715300 DOI: 10.1097/Yic.0B013E32833A4D71 |
0.374 |
|
| 2010 |
de Leeuw AS, Oranje B, van Megen HJ, Kemner C, Westenberg HG. Sensory gating and sensorimotor gating in medication-free obsessive-compulsive disorder patients. International Clinical Psychopharmacology. 25: 232-40. PMID 20568657 DOI: 10.1097/Yic.0B013E328338C4F0 |
0.359 |
|
| 2010 |
Fluitman S, Denys D, Vulink N, Schutters S, Heijnen C, Westenberg H. Lipopolysaccharide-induced cytokine production in obsessive-compulsive disorder and generalized social anxiety disorder. Psychiatry Research. 178: 313-6. PMID 20452055 DOI: 10.1016/J.Psychres.2009.05.008 |
0.361 |
|
| 2010 |
Fluitman SB, Denys DA, Heijnen CJ, Westenberg HG. Disgust affects TNF-alpha, IL-6 and noradrenalin levels in patients with obsessive-compulsive disorder. Psychoneuroendocrinology. 35: 906-11. PMID 20044210 DOI: 10.1016/J.Psyneuen.2009.12.005 |
0.361 |
|
| 2010 |
Kas MJ, Gelegen C, van Nieuwerburgh F, Westenberg HG, Deforce D, Denys D. Compulsivity in mouse strains homologous with chromosomes 7p and 15q linked to obsessive-compulsive disorder. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 153: 252-9. PMID 19514050 DOI: 10.1002/Ajmg.B.30994 |
0.308 |
|
| 2009 |
Van Nieuwerburgh FC, Denys DA, Westenberg HG, Deforce DL. Response to serotonin reuptake inhibitors in OCD is not influenced by common CYP2D6 polymorphisms. International Journal of Psychiatry in Clinical Practice. 13: 345-348. PMID 20174590 DOI: 10.3109/13651500902903016 |
0.336 |
|
| 2009 |
Vulink NC, Denys D, Fluitman SB, Meinardi JC, Westenberg HG. Quetiapine augments the effect of citalopram in non-refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled study of 76 patients. The Journal of Clinical Psychiatry. 70: 1001-8. PMID 19497245 DOI: 10.4088/Jcp.08M04269 |
0.401 |
|
| 2009 |
Westenberg HG. Recent advances in understanding and treating social anxiety disorder. Cns Spectrums. 14: 24-33. PMID 19238127 DOI: 10.1017/S1092852900027267 |
0.393 |
|
| 2009 |
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 823-32. PMID 19154656 DOI: 10.1017/S1461145708009814 |
0.437 |
|
| 2009 |
Geuze E, Vermetten E, de Kloet CS, Hijman R, Westenberg HG. Neuropsychological performance is related to current social and occupational functioning in veterans with posttraumatic stress disorder. Depression and Anxiety. 26: 7-15. PMID 18800372 DOI: 10.1002/Da.20476 |
0.307 |
|
| 2008 |
de Leeuw AS, Westenberg HG. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo. Journal of Psychiatric Research. 42: 894-901. PMID 18533183 DOI: 10.1016/J.Jpsychires.2007.09.001 |
0.34 |
|
| 2008 |
van der Wee NJ, van Veen JF, Stevens H, van Vliet IM, van Rijk PP, Westenberg HG. Increased serotonin and dopamine transporter binding in psychotropic medication-naive patients with generalized social anxiety disorder shown by 123I-beta-(4-iodophenyl)-tropane SPECT. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 757-63. PMID 18413401 DOI: 10.2967/jnumed.107.045518 |
0.554 |
|
| 2008 |
de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder. Psychoneuroendocrinology. 33: 313-20. PMID 18215470 DOI: 10.1016/J.Psyneuen.2007.11.016 |
0.333 |
|
| 2008 |
Geuze E, Vermetten E, de Kloet CS, Westenberg HG. Precuneal activity during encoding in veterans with posttraumatic stress disorder. Progress in Brain Research. 167: 293-7. PMID 18037028 DOI: 10.1016/S0079-6123(07)67026-5 |
0.316 |
|
| 2008 |
de Kloet CS, Vermetten E, Geuze E, Lentjes EG, Heijnen CJ, Stalla GK, Westenberg HG. Elevated plasma corticotrophin-releasing hormone levels in veterans with posttraumatic stress disorder. Progress in Brain Research. 167: 287-91. PMID 18037027 DOI: 10.1016/S0079-6123(07)67025-3 |
0.327 |
|
| 2008 |
Geuze E, van Berckel BN, Lammertsma AA, Boellaard R, de Kloet CS, Vermetten E, Westenberg HG. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Molecular Psychiatry. 13: 74-83, 3. PMID 17667960 DOI: 10.1038/Sj.Mp.4002054 |
0.312 |
|
| 2008 |
de Kloet CS, Vermetten E, Geuze E, Wiegant VM, Westenberg HG. Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder. Journal of Psychiatric Research. 42: 192-8. PMID 17222428 DOI: 10.1016/J.Jpsychires.2006.11.009 |
0.345 |
|
| 2007 |
Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. The Journal of Clinical Psychiatry. 68: 747-53. PMID 17503984 DOI: 10.4088/Jcp.V68N0512 |
0.366 |
|
| 2007 |
Van Veen JF, Van der Wee NJ, Fiselier J, Van Vliet IM, Westenberg HG. Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine (m-CPP) in patients with generalized social anxiety disorder, panic disorder and healthy controls. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 637-42. PMID 17481859 DOI: 10.1016/J.Euroneuro.2007.03.005 |
0.582 |
|
| 2007 |
de Kloet CS, Vermetten E, Heijnen CJ, Geuze E, Lentjes EG, Westenberg HG. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder. Psychoneuroendocrinology. 32: 215-26. PMID 17296270 DOI: 10.1016/J.Psyneuen.2006.12.009 |
0.335 |
|
| 2007 |
de Geus F, Denys D, Westenberg HG. Effects of quetiapine on cognitive functioning in obsessive-compulsive disorder. International Clinical Psychopharmacology. 22: 77-84. PMID 17293707 DOI: 10.1097/Yic.0B013E32801182F7 |
0.35 |
|
| 2007 |
de Kloet CS, Vermetten E, Bikker A, Meulman E, Geuze E, Kavelaars A, Westenberg HG, Heijnen CJ. Leukocyte glucocorticoid receptor expression and immunoregulation in veterans with and without post-traumatic stress disorder. Molecular Psychiatry. 12: 443-53. PMID 17245326 DOI: 10.1038/Sj.Mp.4001934 |
0.313 |
|
| 2007 |
de Geus F, Denys DA, Sitskoorn MM, Westenberg HG. Attention and cognition in patients with obsessive-compulsive disorder. Psychiatry and Clinical Neurosciences. 61: 45-53. PMID 17239038 DOI: 10.1111/J.1440-1819.2007.01609.X |
0.342 |
|
| 2007 |
Geuze E, Westenberg HG, Jochims A, de Kloet CS, Bohus M, Vermetten E, Schmahl C. Altered pain processing in veterans with posttraumatic stress disorder. Archives of General Psychiatry. 64: 76-85. PMID 17199057 DOI: 10.1001/Archpsyc.64.1.76 |
0.303 |
|
| 2007 |
van der Wee NJ, Ramsey NF, van Megen HJ, Denys D, Westenberg HG, Kahn RS. Spatial working memory in obsessive-compulsive disorder improves with clinical response: A functional MRI study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 16-23. PMID 16797166 DOI: 10.1016/J.Euroneuro.2006.04.012 |
0.612 |
|
| 2007 |
Westenberg HG, Fineberg NA, Denys D. Neurobiology of Obsessive-Compulsive Disorder: Serotonin and Beyond Cns Spectrums. 12: 14-27. DOI: 10.1017/S1092852900002479 |
0.375 |
|
| 2007 |
Zohar J, Westenberg H, Stein D, Hollander E. The Cape Town consensus statement regarding the diagnosis and treatment of obsessive-compulsive disorder European Psychiatry. 22: S295. DOI: 10.1016/J.Eurpsy.2007.01.999 |
0.338 |
|
| 2006 |
Montagne B, Schutters S, Westenberg HG, van Honk J, Kessels RP, de Haan EH. Reduced sensitivity in the recognition of anger and disgust in social anxiety disorder. Cognitive Neuropsychiatry. 11: 389-401. PMID 17354077 DOI: 10.1080/13546800444000254 |
0.34 |
|
| 2006 |
Fineberg NA, Stein DJ, Premkumar P, Carey P, Sivakumaran T, Vythilingum B, Seedat S, Westenberg H, Denys D. Adjunctive quetiapine for serotonin reuptake inhibitor-resistant obsessive-compulsive disorder: a meta-analysis of randomized controlled treatment trials. International Clinical Psychopharmacology. 21: 337-43. PMID 17012980 DOI: 10.1097/01.Yic.0000215083.57801.11 |
0.404 |
|
| 2006 |
Van Liempt S, Vermetten E, Geuze E, Westenberg H. Pharmacotherapeutic treatment of nightmares and insomnia in posttraumatic stress disorder: An overview of the literature Annals of the New York Academy of Sciences. 1071: 502-507. PMID 16891608 DOI: 10.1196/Annals.1364.053 |
0.329 |
|
| 2006 |
van der Wee NJ, Hardeman HH, Ramsey NF, Raemaekers M, Van Megen HJ, Denys DA, Westenberg HG, Kahn RS. Saccadic abnormalities in psychotropic-naive obsessive-compulsive disorder without co-morbidity. Psychological Medicine. 36: 1321-6. PMID 16734943 DOI: 10.1017/S0033291706007926 |
0.577 |
|
| 2006 |
van Liempt S, Vermetten E, Geuze E, Westenberg HG. Pharmacotherapy for disordered sleep in post-traumatic stress disorder: a systematic review. International Clinical Psychopharmacology. 21: 193-202. PMID 16687990 DOI: 10.1097/00004850-200607000-00001 |
0.344 |
|
| 2006 |
Vulink NC, Denys D, Bus L, Westenberg HG. Female hormones affect symptom severity in obsessive-compulsive disorder. International Clinical Psychopharmacology. 21: 171-5. PMID 16528139 DOI: 10.1097/01.Yic.0000199454.62423.99 |
0.326 |
|
| 2006 |
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention. Journal of Psychopharmacology (Oxford, England). 20: 789-98. PMID 16478755 DOI: 10.1177/0269881106061712 |
0.433 |
|
| 2006 |
Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG. Association between serotonergic candidate genes and specific phenotypes of obsessive compulsive disorder. Journal of Affective Disorders. 91: 39-44. PMID 16443280 DOI: 10.1016/J.Jad.2005.12.011 |
0.35 |
|
| 2006 |
Denys D, Van Nieuwerburgh F, Deforce D, Westenberg H. Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive-compulsive disorder in males. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 446-50. PMID 16427255 DOI: 10.1016/J.Euroneuro.2005.12.001 |
0.344 |
|
| 2006 |
Sommer IE, Oranje B, Ramsey NF, Klerk FA, Mandl RC, Westenberg HG, Kahn RS. The influence of amphetamine on language activation: an fMRI study. Psychopharmacology. 183: 387-93. PMID 16284750 DOI: 10.1007/S00213-005-0176-3 |
0.377 |
|
| 2006 |
de Kloet CS, Vermetten E, Geuze E, Kavelaars A, Heijnen CJ, Westenberg HG. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review. Journal of Psychiatric Research. 40: 550-67. PMID 16214171 DOI: 10.1016/J.Jpsychires.2005.08.002 |
0.308 |
|
| 2006 |
Fineberg NA, Stein DJ, Carey P, Vythilingum B, Sivakumaran T, Seedat S, Westenberg H, Denys D, Premkumar P. P.4.c.001 Adjunctive quetiapine for SRI-resistant obsessive compulsive disorder: a meta-analysis of three randomised controlled treatment trials European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70612-5 |
0.328 |
|
| 2005 |
Bergink V, Westenberg HG. Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740. International Clinical Psychopharmacology. 20: 291-3. PMID 16192835 DOI: 10.1097/00004850-200511000-00001 |
0.391 |
|
| 2005 |
Tenneij NH, van Megen HJ, Denys DA, Westenberg HG. Behavior therapy augments response of patients with obsessive-compulsive disorder responding to drug treatment. The Journal of Clinical Psychiatry. 66: 1169-75. PMID 16187776 DOI: 10.4088/Jcp.V66N0913 |
0.336 |
|
| 2005 |
van der Stelt HM, Breuer ME, Olivier B, Westenberg HG. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biological Psychiatry. 57: 1061-7. PMID 15860347 DOI: 10.1016/J.Biopsych.2004.12.040 |
0.302 |
|
| 2005 |
Schutters SI, van Megen HJ, Westenberg HG. Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study. The Journal of Clinical Psychiatry. 66: 540-2. PMID 15816800 DOI: 10.4088/Jcp.V66N0420B |
0.33 |
|
| 2005 |
Ho Pian KL, van Megen HJ, Ramsey NF, Mandl R, van Rijk PP, Wynne HJ, Westenberg HG. Decreased thalamic blood flow in obsessive-compulsive disorder patients responding to fluvoxamine. Psychiatry Research. 138: 89-97. PMID 15766633 DOI: 10.1016/J.Pscychresns.2004.12.003 |
0.359 |
|
| 2005 |
Vulink NC, Denys D, Westenberg HG. Bupropion for patients with obsessive-compulsive disorder: an open-label, fixed-dose study. The Journal of Clinical Psychiatry. 66: 228-30. PMID 15705009 DOI: 10.4088/Jcp.V66N0211 |
0.426 |
|
| 2004 |
Denys D, de Geus F, van Megen HJ, Westenberg HG. Use of factor analysis to detect potential phenotypes in obsessive-compulsive disorder. Psychiatry Research. 128: 273-80. PMID 15541785 DOI: 10.1016/J.Psychres.2003.11.005 |
0.335 |
|
| 2004 |
Oranje B, Gispen-de Wied CC, Westenberg HG, Kemner C, Verbaten MN, Kahn RS. Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating. Journal of Psychopharmacology (Oxford, England). 18: 388-94. PMID 15358983 DOI: 10.1177/026988110401800310 |
0.426 |
|
| 2004 |
van der Wee NJ, Fiselier J, van Megen HJ, Westenberg HG. Behavioural effects of rapid intravenous administration of meta-chlorophenylpiperazine in patients with panic disorder and controls. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 413-7. PMID 15336303 DOI: 10.1016/J.Euroneuro.2004.01.001 |
0.569 |
|
| 2004 |
Denys D, de Geus F, van Megen HJ, Westenberg HG. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. The Journal of Clinical Psychiatry. 65: 1040-8. PMID 15323587 DOI: 10.4088/Jcp.V65N0803 |
0.399 |
|
| 2004 |
Denys D, de Geus F, van Megen HJ, Westenberg HG. Symptom dimensions in obsessive-compulsive disorder: factor analysis on a clinician-rated scale and a self-report measure. Psychopathology. 37: 181-9. PMID 15240990 DOI: 10.1159/000079509 |
0.311 |
|
| 2004 |
Denys D, Tenney N, van Megen HJ, de Geus F, Westenberg HG. Axis I and II comorbidity in a large sample of patients with obsessive-compulsive disorder. Journal of Affective Disorders. 80: 155-62. PMID 15207928 DOI: 10.1016/S0165-0327(03)00056-9 |
0.382 |
|
| 2004 |
Denys D, Fluitman S, Kavelaars A, Heijnen C, Westenberg H. Decreased TNF-alpha and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology. 29: 945-52. PMID 15177711 DOI: 10.1016/J.Psyneuen.2003.08.008 |
0.325 |
|
| 2004 |
Denys D, Klompmakers AA, Westenberg HG. Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine. Psychopharmacology. 176: 195-203. PMID 15138756 DOI: 10.1007/S00213-004-1880-0 |
0.31 |
|
| 2004 |
Denys D, van der Wee N, Janssen J, De Geus F, Westenberg HG. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biological Psychiatry. 55: 1041-5. PMID 15121489 DOI: 10.1016/J.Biopsych.2004.01.023 |
0.568 |
|
| 2004 |
Denys D, van Megen HJ, van der Wee N, Westenberg HG. A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. The Journal of Clinical Psychiatry. 65: 37-43. PMID 14744166 DOI: 10.4088/Jcp.V65N0106 |
0.606 |
|
| 2004 |
Westenberg HG, Stein DJ, Yang H, Li D, Barbato LM. A double-blind placebo-controlled study of controlled release fluvoxamine for the treatment of generalized social anxiety disorder. Journal of Clinical Psychopharmacology. 24: 49-55. PMID 14709947 DOI: 10.1016/S0924-977X(03)92143-2 |
0.348 |
|
| 2003 |
Tenney NH, Schotte CK, Denys DA, van Megen HJ, Westenberg HG. Assessment of DSM-IV personality disorders in obsessive-compulsive disorder: comparison of clinical diagnosis, self-report questionnaire, and semi-structured interview. Journal of Personality Disorders. 17: 550-61. PMID 14744080 DOI: 10.1521/Pedi.17.6.550.25352 |
0.354 |
|
| 2003 |
Denys D, van der Wee N, van Megen HJ, Westenberg HG. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. Journal of Clinical Psychopharmacology. 23: 568-75. PMID 14624187 DOI: 10.1097/01.Jcp.0000095342.32154.54 |
0.624 |
|
| 2003 |
Stein DJ, Westenberg HG, Yang H, Li D, Barbato LM. Fluvoxamine CR in the long-term treatment of social anxiety disorder: the 12- to 24-week extension phase of a multicentre, randomized, placebo-controlled trial. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 6: 317-23. PMID 14604447 DOI: 10.1017/S146114570300364X |
0.37 |
|
| 2003 |
Denys D, Burger H, van Megen H, de Geus F, Westenberg H. A score for predicting response to pharmacotherapy in obsessive-compulsive disorder. International Clinical Psychopharmacology. 18: 315-22. PMID 14571151 DOI: 10.1097/01.Yic.0000097036.25861.96 |
0.361 |
|
| 2003 |
Overtoom CC, Verbaten MN, Kemner C, Kenemans JL, van Engeland H, Buitelaar JK, van der Molen MW, van der Gugten J, Westenberg H, Maes RA, Koelega HS. Effects of methylphenidate, desipramine, and L-dopa on attention and inhibition in children with Attention Deficit Hyperactivity Disorder. Behavioural Brain Research. 145: 7-15. PMID 14529800 DOI: 10.1016/S0166-4328(03)00097-4 |
0.315 |
|
| 2003 |
Baldwin D, Broich K, Fritze J, Kasper S, Westenberg H, Möller H. Placebo-controlled studies in depression: necessary, ethical and feasible European Archives of Psychiatry and Clinical Neuroscience. 253: 22-28. PMID 12664309 DOI: 10.1007/S00406-003-0400-2 |
0.315 |
|
| 2003 |
Tenney NH, Denys DA, van Megen HJ, Glas G, Westenberg HG. Effect of a pharmacological intervention on quality of life in patients with obsessive-compulsive disorder. International Clinical Psychopharmacology. 18: 29-33. PMID 12490772 DOI: 10.1097/00004850-200301000-00005 |
0.316 |
|
| 2002 |
Denys D, van Megen H, Westenberg H. Quetiapine addition to serotonin reuptake inhibitor treatment in patients with treatment-refractory obsessive-compulsive disorder: an open-label study. The Journal of Clinical Psychiatry. 63: 700-3. PMID 12197450 DOI: 10.4088/Jcp.V63N0807 |
0.401 |
|
| 2002 |
Scheepers FE, Gispen-De Wied CC, Westenberg HG, Kahn RS. Effect of olanzapine on glutamate levels in cerebrospinal fluid of patients with schizophrenia. Journal of Clinical Psychopharmacology. 22: 333-4. PMID 12006906 DOI: 10.1097/00004714-200206000-00016 |
0.385 |
|
| 2002 |
Snoek H, van Goozen SH, Matthys W, Sigling HO, Koppeschaar HP, Westenberg HG, van Engeland H. Serotonergic functioning in children with oppositional defiant disorder: a sumatriptan challenge study. Biological Psychiatry. 51: 319-25. PMID 11958783 DOI: 10.1016/S0006-3223(01)01230-6 |
0.313 |
|
| 2001 |
Scheepers FE, Gispen-de Wied CC, Westenberg HG, Kahn RS. The effect of olanzapine treatment on monoamine metabolite concentrations in the cerebrospinal fluid of schizophrenic patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 468-75. PMID 11557160 DOI: 10.1016/S0893-133X(01)00250-0 |
0.473 |
|
| 2001 |
Maes M, van West D, De Vos N, Westenberg H, Van Hunsel F, Hendriks D, Cosyns P, Scharpé S. Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 37-46. PMID 11106874 DOI: 10.1016/S0893-133X(00)00177-9 |
0.3 |
|
| 2000 |
Rinne T, Westenberg HG, den Boer JA, van den Brink W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biological Psychiatry. 47: 548-56. PMID 10715361 DOI: 10.1016/S0006-3223(99)00181-X |
0.345 |
|
| 1999 |
Westenberg HG. Facing the challenge of social anxiety disorder. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 9: S93-9. PMID 10523064 DOI: 10.1016/S0924-977X(99)00029-2 |
0.378 |
|
| 1999 |
Goozen SHMv, Matthys W, Cohen-Kettenis PT, Westenberg H, Engeland Hv. Plasma monoamine metabolites and aggression: two studies of normal and oppositional defiant disorder children. European Neuropsychopharmacology. 9: 141-147. PMID 10082240 DOI: 10.1016/S0924-977X(98)00019-4 |
0.319 |
|
| 1998 |
Klaassen T, Ho Pian KL, Westenberg HG, den Boer JA, van Praag HM. Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine. Psychiatry Research. 79: 207-12. PMID 9704867 DOI: 10.1016/S0165-1781(98)00044-4 |
0.32 |
|
| 1997 |
Maes M, Westenberg H, Vandoolaeghe E, Demedts P, Wauters A, Neels H, Meltzer HY. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine. Journal of Clinical Psychopharmacology. 17: 358-64. PMID 9315986 DOI: 10.1097/00004714-199710000-00004 |
0.336 |
|
| 1996 |
van Berckel BN, Hijman R, van der Linden JA, Westenberg HG, van Ree JM, Kahn RS. Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients. Biological Psychiatry. 40: 1298-300. PMID 8959296 DOI: 10.1016/S0006-3223(96)00311-3 |
0.414 |
|
| 1995 |
BUITELAAR JK, COHEN-KETTENIS P, VLUTTERS H, WESTENBERG H, SANDELL L. Remoxipride in Adolescents with Tourette's Syndrome: An Open Pilot Study Journal of Child and Adolescent Psychopharmacology. 5: 121-128. DOI: 10.1089/Cap.1995.5.121 |
0.335 |
|
| 1994 |
Bradwejn J, Koszycki D, Tertre ACd, Megen Hv, Boer Jd, Westenberg H, Annable L. The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260,a central cholecystokinin receptor antagonist, in patients with panic disorder Archives of General Psychiatry. 51: 486-493. PMID 8192551 DOI: 10.1001/Archpsyc.1994.03950060050005 |
0.333 |
|
| 1987 |
Kahn RS, Westenberg HG, Verhoeven WM, Gispen-de Wied CC, Kamerbeek WD. Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo. International Clinical Psychopharmacology. 2: 33-45. PMID 3312397 DOI: 10.1097/00004850-198701000-00003 |
0.511 |
|
| 1987 |
den Boer JA, Westenberg HG, Kamerbeek WD, Verhoeven WM, Kahn RS. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology. 2: 21-32. PMID 3117876 DOI: 10.1097/00004850-198701000-00002 |
0.508 |
|
| 1985 |
Kahn RS, Westenberg HG. L-5-hydroxytryptophan in the treatment of anxiety disorders. Journal of Affective Disorders. 8: 197-200. PMID 3157732 DOI: 10.1016/0165-0327(85)90046-1 |
0.466 |
|
| 1981 |
Verhoeven WM, Westenberg HG, Gerritsen TW, van Praag HM, Thijssen JH, Schwarz F, van Ree JM, de Wied D. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects. Psychiatry Research. 5: 293-309. PMID 7034028 DOI: 10.1016/0165-1781(81)90076-7 |
0.496 |
|
| 1981 |
de Cuyper HJ, van Praag HM, Mulder-Hajonides WR, Westenberg HG, de Zeeuw RA. Pharmacokinetics of clomipramine in depressive patients. Psychiatry Research. 4: 147-56. PMID 6939006 DOI: 10.1016/0165-1781(81)90018-4 |
0.532 |
|
| 1980 |
De Zeeuw RA, Westenberg HG, Van Praag HM, De Cuyper H. Unusual plasma level oscillations of clomipramine in man: a pharmacokinetic and pharmacodynamic dilemma. Postgraduate Medical Journal. 56: 120-6. PMID 7393821 |
0.48 |
|
| 1979 |
de Zeeuw RA, Westenberg HG, Vander Kleijn E, Gimbrere JS. An unusual case of carbamazepine poisoning with a near-fatal relapse after two days. Veterinary and Human Toxicology. 21: 95-7. PMID 506000 |
0.464 |
|
| 1979 |
de Zeeuw RA, Westenberg HG, van der Kleijn E, Gimbrère JS. An unusual case of carbamazepine poisoning with a near-fatal relapse after two days. Clinical Toxicology. 14: 263-9. PMID 455916 DOI: 10.3109/15563657908992443 |
0.464 |
|
| 1978 |
Westenberg HG, van der Kleijn E, Oei TT, de Zeeuw RA. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva. Clinical Pharmacology and Therapeutics. 23: 320-8. PMID 627139 |
0.481 |
|
| 1978 |
de Zeeuw RA, Westenberg HG. A Rapid Screening Procedure for Tricyclic Antidepressant Drugs in Body Fluids by Means of High-Performance Liquid Chromatography1 Journal of Analytical Toxicology. 2: 229-232. DOI: 10.1093/jat/2.6.229 |
0.427 |
|
| 1977 |
Westenberg HG, Drenth BF, de Zeeuw RA, de Cuyper H, van Praag HM, Korf J. Determination of clomipramine and desmethylclomipramine in plasma by means of liquid chromatography. Journal of Chromatography. 142: 725-33. PMID 914945 |
0.455 |
|
| 1977 |
Westenberg HG, de Zeeuw RA, van de Kleijn E, Oei TT. Relationship between carbamazepine concentrations in plasma and saliva in man as determined by liquid chromatography. Clinica Chimica Acta; International Journal of Clinical Chemistry. 79: 155-61. PMID 890949 |
0.46 |
|
| 1977 |
Westenberg HG, De Zeeuw RA, De Cuyper H, Van Praag HM, Korf J. Bioanalysis and pharmacokinetics of clomipramine and desmethylclomipramine in man by means of liquid chromatography. Postgraduate Medical Journal. 53: 124-30. PMID 600889 |
0.412 |
|
| 1976 |
Westenberg HG, de Zeeuw RA. Rapid and sensitive liquid chromatographic determination of carbamazepine suitable for use in monitoring multiple-drug anticonvulsant therapy. Journal of Chromatography. 118: 217-24. PMID 176168 |
0.448 |
|
| Show low-probability matches. |
